DexCom (DXCM) closed the most recent trading day at $125.45, moving +0.8% from the previous trading session.
DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 Mid-Cap Stocks Poised for a Breakout in 2024

06:10pm, Tuesday, 16'th Jan 2024
Important voices in the investment world predict that 2024 could be a very strong year for mid-cap stocks. Janus Henderson portfolio manager Brian Demain believes the outlook for mid caps looks favora
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h
Growth stocks are the best way to compound your portfolio. After all, growth has outperformed value since 2010 by a huge margin.
DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by strong demand for its CGM sensors across the globe. It delivers robust revenue guidance for 2024.
Sarepta Therapeutics boasts excellent innovative abilities and a deep pipeline. DexCom still has a huge growth runway left in the continuous glucose monitoring market.
The COVID-19 pandemic highlighted the sometimes fragile nature of the American healthcare system. Many people had to delay elective surgeries and forego other treatments for an extended period.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.
DexCom (DXCM) closed at $123.98 in the latest trading session, marking a +1.76% move from the prior day.

3 Medical-Device Stocks Could Click in 2024

02:30pm, Tuesday, 26'th Dec 2023
Baird is bullish on Boston Scientific, Insulet, and DexCom, stocks set to benefit as those companies ramp up sales.
Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024.
These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap Amazon.com (AMZN), Deckers Outdoor (DECK), Wingstop (WING), DexCom (DXCM) and NVIDIA (NVDA).
In the closing of the recent trading day, DexCom (DXCM) stood at $122.17, denoting a -0.51% change from the preceding trading day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE